trial · primary record
Adebrelimab (SHR-1316) + chemotherapy
Non-small Cell Lung Cancer (NSCLC)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1088 |
| Primary completion | 2034-12-31 |
| Primary endpoint | EFS |
| Registry ID | NCT07895238 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:43.355Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07895238
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.